Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds from the offering are expected to be approximately $3.9 million before deducting fees and expenses.
The offering is set to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Approximately $3.9 million before deductions.
Closing Date
August 15, 2025, subject to customary conditions.
Placement Agent
Maxim Group LLC is the sole placement agent.
Offering Registration
Pursuant to effective shelf registration statement on Form S-3.
- The gross proceeds of $3.9 million will provide liquidity for Scienture Holdings, Inc.
- The successful offering indicates investor confidence in the company's future prospects.
The registered direct offering signifies a strategic move by Scienture Holdings, Inc. to raise capital for its pharmaceutical operations.